Fifth Lane Capital’s C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share CXAC.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding CXAC.WS
RCM
BFM
SCM
SCM
LA
AA
HCM
PAMP
MI
Fifth Lane Capital's CXAC.WS Position: Q3 2022 in Review
Fifth Lane Capital sold out of C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (CXAC.WS) in Q3 2022, closing a stake of 37,707 shares — an estimated $8K sold.
Fifth Lane Capital first reported a position in CXAC.WS in Q1 2022 and held it in 2 quarters. The position peaked at $13K in Q1 2022. 39 funds tracked by Wall St. Rank hold CXAC.WS as of Q3 2022.
- Fifth Lane Capital reported no remaining C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q3 2022 after selling out during the quarter.
- Fifth Lane Capital sold 37,707 C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q3 2022, an estimated $8K.
- Fifth Lane Capital first reported a position in C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q1 2022 and held it in 2 quarters.
- Fifth Lane Capital's C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $13K in Q1 2022.
- 39 funds tracked by Wall St. Rank held C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q3 2022.
Based on Fifth Lane Capital's 13F filing for Q3 2022, filed 14 Nov 2022.